Overview
Romain Riscal practices practicing medicine in Montpellier, France.
His clinical expertise encompasses Dihydrolipoamide Dehydrogenase Deficiency, Liposarcoma, and Renal Cell Carcinoma (RCC).
He is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Romain Riscal
Is Romain Riscal a top-rated expert for Dihydrolipoamide Dehydrogenase Deficiency?
MediFind is an objective health platform that identifies experts based on real-world data. Romain Riscal is classified as an Experienced expert for Dihydrolipoamide Dehydrogenase Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Romain Riscal participate in research or clinical trials?
Yes. Romain Riscal has published 18 articles and abstracts on conditions like Dihydrolipoamide Dehydrogenase Deficiency. You can view a list of Romain Riscal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Dihydrolipoamide Dehydrogenase Deficiency
- LiposarcomaMr. Riscal isExperienced. Learn about Liposarcoma.
- Renal Cell Carcinoma (RCC)Mr. Riscal isExperienced. Learn about Renal Cell Carcinoma (RCC).